EFFICACY AND SAFETY OF INGENOL MEBUTATE GEL IN FIELD TREATMENT OF ACTINIC KERATOSIS ON FULL FACE, BALDING SCALP OR APPROXIMATELY 250 CM2 ON THE CHEST

Registry ID

LP0105-1032

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

LEO PHARMA AS

Start date

2015-04-01

Last update

2015-04-09

Conditions

• ACTINIC KERATOSIS

Related clinical trials

• SAFETY AND EFFICACY OF ESCALATING DOSES OF LEO 43204 APPLIED ONCE DAILY FOR TWO CONSECUTIVE DAYS ON APPROXIMATELY 250 CM2 ON TRUNK AND EXTREMITIES IN SUBJECTS WITH ACTINIC KERATOSIS. PART 2 (CANADA): A PHASE 2, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, VEHICLE-CONTROLLED, 8-WEEK TRIAL
• LEO SAFETY AND EFFICACY OF ESCALATING DOSES OF TWO LEO 43204 FORMULATIONS APPLIED ONCE DAILY FOR TWO CONSECUTIVE DAYS ON FULL FACE OR APPROXIMATELY 250 CM2 (40 IN2) ON THE CHEST IN SUBJECTS WITH ACTINIC KERATOSIS; PART 2: A PHASE 2, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, VEHICLE-CONTROLLED, 8-WEEK TRIAL OF LEO 43204 GEL IN SUBJECTS WITH AK (CANADA AND US)

View on source registry